bandaram-pharma-packtech-ltd
Bandaram Pharma Packtech Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|
Revenue | 3.17 | 2.72 | 1.52 |
Operating Expense | 2.83 | 2.97 | 1.53 |
Net Profit | 0.33 | -0.25 | -0.02 |
Net Profit Margin | 10.41 | -9.19 | -1.32 |
Earning Per Share | 0.28 | -0.21 | -0.01 |
EBIDTA | 0.33 | -0.25 | -0.01 |
Effective Tax Rate | TBA | TBA | TBA |
Particulars | Sep 2024 |
---|---|
Revenue | 3.17 |
Operating Expense | 2.83 |
Net Profit | 0.33 |
Net Profit Margin | 10.41 |
Earning Per Share | 0.28 |
EBIDTA | 0.33 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Total Revenue Annual | 14.84 | 10.09 | TBA |
Operating Expenses Annual | 14.68 | 9.82 | 0.01 |
Operating Profit Annual | 0.19 | 0.27 | -0.01 |
Interest Annual | TBA | 0.00 | 0.00 |
Depreciation | 0.02 | 0.00 | TBA |
Net Profit Annual | 0.13 | 0.20 | -0.01 |
Tax Annual | 0.04 | 0.07 | TBA |
Particulars | Mar 2024 |
---|---|
Total Revenue Annual | 14.84 |
Operating Expenses Annual | 14.68 |
Operating Profit Annual | 0.19 |
Interest Annual | TBA |
Depreciation | 0.02 |
Net Profit Annual | 0.13 |
Tax Annual | 0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Cash Flow at the Beginning | 0.09 | 2.08 | TBA |
Cash Flow from Operations | -3.23 | -3.87 | 2.92 |
Cash Flow from Investing | -1.40 | -2.53 | -1.55 |
Cash Flow from Financing | 4.61 | 4.40 | 0.72 |
Cash Flow at the End | 0.07 | 0.09 | 2.08 |
Particulars | Mar 2024 |
---|---|
Cash Flow at the Beginning | 0.09 |
Cash Flow from Operations | -3.23 |
Cash Flow from Investing | -1.40 |
Cash Flow from Financing | 4.61 |
Cash Flow at the End | 0.07 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
PBDIT Margin (%) | 1.28 | 2.68 | TBA |
PBIT Margin (%) | 1.15 | 2.68 | TBA |
PBT Margin (%) | 1.15 | 2.68 | TBA |
Net PROFIT Margin (%) | 0.88 | 1.98 | TBA |
Return On Networth / Equity (%) | 1.70 | 6.60 | TBA |
Return On Networth /Employed (%) | 1.73 | 5.16 | TBA |
Return On Assets (%) | 1.32 | 3.83 | TBA |
Total Debt / Equity (X) | 0.29 | 0.73 | 2.17 |
Asset Turnover Ratio (%) | 1.51 | 1.93 | TBA |
Particulars | Mar 2024 |
---|---|
PBDIT Margin (%) | 1.28 |
PBIT Margin (%) | 1.15 |
PBT Margin (%) | 1.15 |
Net PROFIT Margin (%) | 0.88 |
Return On Networth / Equity (%) | 1.70 |
Return On Networth /Employed (%) | 1.73 |
Return On Assets (%) | 1.32 |
Total Debt / Equity (X) | 0.29 |
Asset Turnover Ratio (%) | 1.51 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Fixed Assets Annual | 0.01 | 0.02 | TBA |
Total Current Assets Annual | 9.43 | 5.74 | 3.00 |
Non Current Assets Annual | 3.92 | 2.53 | TBA |
Total Shareholders Funds Annual | 12.20 | 3.07 | 2.99 |
Total Assets Annual | 13.36 | 8.27 | 3.00 |
Particulars | Mar 2024 |
---|---|
Fixed Assets Annual | 0.01 |
Total Current Assets Annual | 9.43 |
Non Current Assets Annual | 3.92 |
Total Shareholders Funds Annual | 12.20 |
Total Assets Annual | 13.36 |
EPS (INR)
Expected
0.56
Reported
0.06
Surprise
-89.29%
Jun 2024
EPS beaten by -89.29%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%